World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
64
Citations
13464
World Ranking
2629
National Ranking
1060

Christoph Rader publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Christoph Rader sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 213 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Christoph Rader D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Christoph Rader sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 64 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Christoph Rader is affiliated with the Scripps Research Institute in the United States. Their research spans fields including medicine as well as biochemistry, genetics, and molecular biology. Within these domains, their work focuses on molecular biology, radiology, nuclear medicine and imaging, oncology, immunology, and genetics.

Their notable research topics include monoclonal and polyclonal antibodies research, CAR-T cell therapy research, glycosylation and glycoproteins research, chronic lymphocytic leukemia research, advanced biosensing techniques and applications, HER2/EGFR in cancer research, and galectins and cancer biology.

Frequent publication venues for Christoph Rader's work include:

  • Cold Spring Harbor Protocols
  • Blood
  • Nature Communications
  • Oncogene
  • Cancer Research

They have collaborated frequently with researchers such as Haiyong Peng, Jessica Nunes, Natarajan Muthusamy, Dobeen Hwang, and Ajeeth Adhikari.

Among their recent published papers are:

  • SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity (2020, Nature Communications)
  • Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade (2020, Cancer Cell)
  • Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2 (2021, PLoS Pathogens)
  • Antibody-based cancer therapy (2021, Oncogene)
  • Generation and validation of structurally defined antibody-siRNA conjugates (2020, Nucleic Acids Research)

Best Publications

  • SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

    Lizhou Zhang;Cody B. Jackson;Huihui Mou;Amrita Ojha

  • Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells

    Michael Hudecek;Maria Teresa Lupo-Stanghellini;Paula L. Kosasih;Daniel Sommermeyer

  • The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity

    Michael Hudecek;Michael Hudecek;Daniel Sommermeyer;Paula L. Kosasih;Anne Silva-Benedict;Anne Silva-Benedict

  • The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.

    Michael Hudecek;Michael Hudecek;Thomas M. Schmitt;Sivasubramanian Baskar;Maria Teresa Lupo-Stanghellini

  • Phage display of combinatorial antibody libraries.

    Christoph Rader;Carlos F Barbas

  • A phage display approach for rapid antibody humanization: Designed combinatorial V gene libraries

    Christoph Rader;David A. Cheresh;Carlos F. Barbas

  • Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.

    Sivasubramanian Baskar;Ka Yin Kwong;Thomas Hofer;Jessica M Levy

  • Immunogenic Chemotherapy Enhances Recruitment of CAR-T Cells to Lung Tumors and Improves Antitumor Efficacy when Combined with Checkpoint Blockade.

    Shivani Srivastava;Scott N. Furlan;Scott N. Furlan;Carla A. Jaeger-Ruckstuhl;Megha Sarvothama

  • Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting.

    Shivani Srivastava;Alexander I. Salter;Denny Liggitt;Sushma Yechan-Gunja

  • The Nogo-66 Receptor Homolog NgR2 Is a Sialic Acid-Dependent Receptor Selective for Myelin-Associated Glycoprotein

    Karthik Venkatesh;Onanong Chivatakarn;Hakjoo Lee;Pushkar S. Joshi

  • A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease

    Davide Bagnara;Matthew S. Kaufman;Matthew S. Kaufman;Matthew S. Kaufman;Carlo Calissano;Sonia Marsilio

  • Methods for the generation of chicken monoclonal antibody fragments by phage display.

    Jennifer Andris-Widhopf;Christoph Rader;Peter Steinberger;Roberta Fuller

  • Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals

    Tobias Derfuss;Khyati Parikh;Sviataslau Velhin;Magdalena Braun

  • Rabbit Immune Repertoires as Sources for Therapeutic Monoclonal Antibodies: The Impact of Kappa Allotype-correlated Variation in Cysteine Content on Antibody Libraries Selected by Phage Display

    Mikhail Popkov;Rose G. Mage;Cornelius B. Alexander;Sujatha Thundivalappil

  • Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson’s disease – Proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications

    Randall W. Moreadith;Tacey X. Viegas;Michael D. Bentley;J. Milton Harris

  • Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor–Modified T Cells

    Carolina Berger;Carolina Berger;Daniel Sommermeyer;Michael Hudecek;Michael Berger

  • The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies

    Christoph Rader;Gerd Ritter;Sheila Nathan;Marikka Elia

  • From rabbit antibody repertoires to rabbit monoclonal antibodies.

    Justus Weber;Haiyong Peng;Christoph Rader

  • Multiple event activation of a generic prodrug trigger by antibody catalysis

    Doron Shabat;Christoph Rader;Benjamin List;Richard A. Lerner

  • Implications of the HIV-1 Rev dimer structure at 3.2 Å resolution for multimeric binding to the Rev response element

    Michael A. DiMattia;Norman R. Watts;Stephen J. Stahl;Christoph Rader

  • Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B Cells through a PI3-kinase dependent pathway

    Rosa Lapalombella;Leslie Andritsos;Qing Liu;Sarah E. May

Frequent Co-Authors

Carlos F. Barbas
Carlos F. Barbas Scripps Research Institute
Stanley R. Riddell
Stanley R. Riddell University of Washington
Terrence R. Burke
Terrence R. Burke National Institutes of Health
Peter Sonderegger
Peter Sonderegger University of Zurich
John C. Byrd
John C. Byrd University of Pittsburgh Cancer Institute
Richard A. Lerner
Richard A. Lerner Scripps Research Institute
William R. Roush
William R. Roush Scripps Research Institute
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Ben Shen
Ben Shen Scripps Research Institute
Michael C. Jensen
Michael C. Jensen Seattle Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing microbiology, exploring complementary career pathways in healthcare and information management broadens professional opportunities. Specialized certifications such as the certified professional coder (cpc) can enhance understanding of medical data coding—an essential skill in clinical labs and healthcare settings.

Advancing education through a master in health information management salary often leads to leadership roles managing patient data and ensuring regulatory compliance. This degree is in high demand, blending biology knowledge with information technology expertise.

Prospective students should consider the best cahiim accredited him programs online to ensure quality education and industry recognition. Accredited programs provide rigorous training necessary for careers in health information management and related fields.

For those seeking quicker entry, fast online medical billing and coding certification programs are ideal. These programs prepare graduates for essential roles supporting healthcare providers with medical records and billing, complementing a microbiology background focused on laboratory and clinical applications.

Best Scientists Citing Christoph Rader

Trending Scientists

Recently Published Articles